BAX and Alzheimer disease: Upregulation of Bcl-2 and downregulation of Bax (reducing the Bax/Bcl-2 ratio) indicate CSCPs-NPs mitigate mitochondrial apoptosis—a well-established driver of neuronal loss in AD [30,31].